A Site Selection Web Exclusive,
SHARE THIS ON SOCIAL MEDIA
The Buck Institute for Research on Aging in Novato, Calif., was designed by I.M. Pei.
Site Selection readers may recall our interview with leaders at the Buck Institute for Research on Aging (pictured) in Novato, Calif. On April 1, Madison, Wis.-basd Cellular Dynamics International (CDI) announced it is opening a facility at the Institute after receiving a $16-million grant award from theCalifornia Institute of Regenerative Medicine (CIRM) to create and bank human induced pluripotent stem cells (iPSCs).
CDI signed a lease for up to five years in the Buck Institute's partially CIRM-funded stem cell research building. A portion of the space will be subleased to the Coriell Institute for Medical Research to construct a stem cell bank, an activity for which CDI is a subcontractor.
"The CIRM grants provide CDI with the funding to build, with our partner Coriell, the premier iPSC bank," said Bob Palay, CDI's CEO. "We are excited to be working with the Buck Institute, constructing our stem cell derivation laboratories as well as the stem cell bank within their world class facilities."
"As a pioneer in stem cell technology, CDI is a perfect tenant for our new Regenerative Medicine Research Center," said Brian Kennedy, PhD, president and CEO of the . Tom Novak, Ph.D.,vice president of strategic partnerships at CDI, said, "Our location in the Buck Institute, with its focus on improving human ‘healthspan' and researching age-related disease, is a great opportunity for us to interact and collaborate with the top academic scientists in the field. We see this as a great opportunity to draw top talent to CDI's second location."
Ever wonder which locales have the most clinical trials going on, and in which therapeutic areas? Wonder no more: The NIH's site has it covered for you, both domestically and abroad:
ZocDoc founder & CEO Cyrus Massoumi
ZocDoc, a hugely popular free service for patients to find doctors and book appointments instantly online, announced in late March it intends to hire 66 this year and 650 in the next three years at a new office in Scottsdale, Ariz. Founded in 2007 and headquartered in New York City, the company's only other office is in Pune, India, and its total employment today is only 400.
"We are committed to providing first-rate customer service, and we're incredibly proud of our high service standards which include answering within eight seconds of a call," said ZocDoc founder & CEO Cyrus Massoumi. "In turn, patients reward us with their loyalty and by telling others about our service, making ZocDoc one of the most highly-recommended companies in healthcare. By building a team of excellent service and sales professionals in the Phoenix region, we will continue to improve upon the service we provide to patients and doctors every day."
Massoumi was joined at the announcement by Gov. Jan Brewer, Scottsdale Mayor Jim Lane and leaders from the Arizona Commerce Authority and the Greater Phoenix Economic Council (GPEC).
"The Greater Phoenix region has a dynamic healthcare IT cluster that is growing exponentially, just like ZocDoc, whose innovative service is a welcome addition to our community," said GPEC President and CEO Barry Broome said. "Scottsdale's young, university-educated workforce is a perfect fit for ZocDoc's needs and has the added bonus of an urban culture, with walkable restaurants, shops and entertainment venues."
More than 2.5 million patients a month use ZocDoc's service, which is currently available in over 1,700 U.S. cities, making it available to over 40 percent of the U.S. population. ZocDoc also offers a Spanish-language version of its free service called ZocDoc en Espanol (espanol.zocdoc.com; iPhone and Android) that helps Hispanic patients effortlessly find Spanish-speaking doctors and book appointments with them.
The latest annual Health Rankings for every county in every state were just released in , produced by a team at the University of Wisconsin Population Health Institute in collaboration with the Robert Wood Johnson Foundation. The data are downloadable in spreadsheet form with tabs, enabling you to perform your own calculations and rankings based on the variables examined by the team.
This project to be completed by Lingerfelt Companies will complete a $100-million three-building headquarter complex for Health Diagnostic Laboratory, Inc. within the Virginia BioTechnology Research Park in Downtown Richmond.
Image courtesy of McKinney & Co.
The Lingerfelt Companies, headquartered in Richmond, Va., announced April 24 that development has begun on the third phase of BioTech 8, a six-story tower within the 34-acre Virginia BioTechnology Research Park in downtown Richmond. The project will complete the $100-million three-building headquarter complex totaling 276,000 sq. ft., including a four-story, 485-space parking deck. Completion is expected in spring 2014.
The facility is an expansion for Health Diagnostic Laboratory, Inc. (HDL, Inc.), one of the nation's fastest-growing health management companies, a CLIA-certified and CAP-accredited laboratory offering a comprehensive test menu of risk factors and biomarkers for cardiovascular disease, diabetes and related diseases.
The Phase III BioTech 8 expansion for HDL will take total development at the Virginia Biotechnology Research Park to more than 1.25 million sq. ft., where more than 60 public and private bioscience companies are located.
CAPTION: This project to be completed by Lingerfelt Companies will complete a $100-million three-building headquarter complex for Health Diagnostic Laboratory, Inc. within the Virginia BioTechnology Research Park in Downtown Richmond.
Take a peek into the growing profile of the "" from NPR's Planet Money.
Enrique Conterno, president of Lilly Diabetes
Eli Lilly and Co. on April 2 announced that it is "working closely with the city on a proposal to invest an additional $180 million in the company's Indianapolis-based insulin manufacturing operations. The investment is in addition to the company's November 2012 announcement of a $140 million expansion of the company's Indianapolis insulin manufacturing operations." Together, the investments would enable Lilly to meet the growing insulin demand given the rise in diabetes prevalence across the U.S. Lilly also is proposing several other ancillary investment projects totaling about $80 million, including a $40 million product-inspection center.
The latest $180 million proposed investment is two-fold:
- Lilly would add a second insulin cartridge-filling line to the overall scope of the previously announced expansion, bringing the total to two insulin-cartridge-filling lines.
- The second piece of the investment would support Lilly's efforts to increase its insulin-active-ingredient manufacturing capacity. Designed to increase annual insulin output, this effort would help Lilly boost productivity without building a new manufacturing plant or adding to its cost structure. The project also would support Lilly's commitment to maintain the highest quality standards.
Eli Lilly and Co.’s headquarters in Indianapolis
Construction work in the insulin-active-ingredient production area could be completed by December and operational by March 2014. Construction supporting the additional insulin-cartridge-filling line could be completed by 2016. Once operational, approximately 175 full-time, highly skilled, specialized technicians, scientists, and engineers would be needed to manage operations in the cartridge-filling and insulin-active-ingredient manufacturing areas.
"Lilly is making significant investments to support our current portfolio of diabetes medicines," said Enrique Conterno (pictured), president of Lilly Diabetes. "We are also continuing to search for new and better treatment options. We have one of the strongest diabetes pipelines in our history — including four molecules in late-stage development — that could help support the needs of people with diabetes."
The was held earlier this month in the Twin Cities, hosted by the newly relocated in the Mayo Building on the Twin Cities Campus of the University of Minnesota.
The Medical Devices Center (MDC) at the University of Minnesota is an interdisciplinary program that sits within the Institute for Engineering in Medicine and combines basic research, applied and translational research, education and training, and outreach and public engagement all related to medical devices. The MDC brings together the University of Minnesota´s expertise from the Colleges of Science and Engineering and the Academic Health Center (Colleges of Medicine, Dentistry, Veterinary Medicine, Nursing and Pharmacy).
In April 2013, the Medical Devices Center will move to its new 8,000 square foot home located in the Mayo Building on the East Bank Campus. The MDC aims to strengthen interdisciplinary research among faculty in the health sciences and engineering specifically related to medical devices. The center will help train the next generation of medical device inventors and foster new relationships with the successful Twin Cities medical device industry and various government agencies in an effort to improve health care worldwide.
This artist's rendering depicts the main entry of the University of Minnesota's newly expanded Medical Devices Center.
A release from Godsell Construction Corp. says the Long Island firm is keeping busy with hospital renovations.
"New hospital construction has slowed, but renovations are still going strong," says the company's president Arthur Godsell. "And competition is limited because the learning curve is so steep. Hospital renovation requires a whole different style of work. There's more specialty equipment to order, and more power and mechanicals to install. Plus, hospitals don't have off hours. You have to work around the staff and cleanliness is major factor."
Godsell Construction Corp., which employs 75, is currently renovating a 320 slice CT scanner unit in Manhasset, as well as CT scan units in six hospitals across Long Island. It is also renovating the Stem Cell Research Department at Mt. Sinai Hospital. Among its well-known clients are Cushman & Wakefield, Tishman Speyer, North Shore-Long Island Jewish Health System, Winthrop Hospital, Rockefeller Center, and many of the larger general contractors in the New York metropolitan area.
In late March Modern Healthcare ranked Turner Construction Co. the number one construction manager in the United States for the sixth consecutive year, and for 24 of the past 28 years. In 2012, made up 24 percent of Turner's total sales and 20 percent of the company's work in place, and were spread across 20 states. Notable projects in 2012 include:
- The University Medical Center of Princeton at Plainsboro in New Jersey, which doubles the size of the hospital's emergency facilities and demonstrates a commitment to sustainability with features such as a green roof and high-efficiency heating and cooling equipment;
- The South Patient Tower at Inova Fairfax in Falls Church, Va., which adds more than 170 private patient rooms to the hospital's campus;
- Nationwide Children's Hospital in Columbus, Ohio, one of the largest pediatric facilities in the country, which benefited from the use of Lean construction methods and Building Information Modeling (BIM) tools; and
- Kaleida Health's Gates Vascular Institute in Buffalo, N.Y., which features high-efficiency plumbing fixtures and a host of other sustainable elements, equipment, and materials to create an efficient research and treatment facility on the University at Buffalo campus.
"We're proud of our recognition as a leading provider of construction services to healthcare institutions," said Chip Cogswell, vice president and general manager of Turner's Healthcare group. "The $2.6 billion of healthcare projects completed in 2012 represents work on assignments ranging from $1-million dollar renovation and upgrade projects to building programs with a construction volume in excess of $300 million."